Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Isoquinoline ether compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction

Isoquinoline ether compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction

US Patent 10968227 · Granted Apr 6, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Positive modulators of the muscarinic acetylcholine receptor M42025
Positive modulators of the muscarinic acetylcholine receptor M42025
Substituted pyrimido[1,2-b]pyridazines as positive allosteric modulators of the 2025
Substituted pyrimido[1,2-b]pyridazines as positive allosteric modulators of the 2025
Antagonists of the muscarinic acetylcholine receptor M42025
Antagonists of the muscarinic acetylcholine receptor M42025
Indazole compounds as mGluR4 allosteric potentiators, compositions, and methods 2025
Indazole compounds as mGluR4 allosteric potentiators, compositions, and methods 2025
Indazole compounds as mGluR4 allosteric potentiators, compositions, and methods 2025
Positive allosteric modulators of the muscarinic acetylcholine receptor M42024
Positive allosteric modulators of the muscarinic acetylcholine receptor M12024
Substituted pyrimido[1,2-b]pyridazines as positive allosteric modulators of the 2024